https://www.thebodypro.com/tag/id-week

IDWeek

The Latest

Jacob Lalezari, M.D., and Daniel Kuritzkes, M.D.

Extensively Drug-Resistant HIV Yields to a New Drug: Ibalizumab

HIV clinicians who have patients in declining health due to extensive HIV drug resistance may soon have a new lifesaving option. Ibalizumab, an HIV entry inhibitor in development, shows highly encouraging antiretroviral activity in the days after it ...

Joseph Eron Jr., M.D.

If at First an HIV Viral Load Blips, Test, Test (the Same Sample) Again

If an HIV-positive patient's viral load test results come back between 50 copies/mL and 200 copies/mL, consider retesting the same blood sample, Joseph Eron Jr., M.D., recommends. New study results suggest that the retest results may alter a clinicia...

Gretchen Volpe, M.D., M.P.H.

Over Time, High-Dose Omega-3 May Improve Some Cardiovascular Measures in People With HIV

High-dose, long-term omega-3 supplementation appears to yield improved triglycerides and C-reactive protein levels among HIV-positive people who have elevated triglycerides, but only after more than a year of use, a new study has found.

Brian Wood, M.D.

Benefits and Barriers to Decentralized HIV Care for Patients in Underserved Communities

People living with HIV who must travel long distances to their HIV care providers -- or are out of care due to a shortage of local providers -- are highly vulnerable to disease progression, which increases the likelihood of transmitting HIV. Brian Wo...

Mark S. Freedman, M.P.H.

Anal Cancer Screening Uncommon Among HIV-Positive MSM in Care

Anal cancer screening was uncommon -- at only 11% -- among a study of HIV-positive men who have sex with men (MSM) receiving HIV care, despite this community being at a significantly higher risk for anal cancer, according to a study presented at IDWe...

Promo Image

A Review of Long-Acting HIV Treatment and Prevention

As we inch closer to an HIV cure, the next big step is making long-acting antiretroviral therapy the norm and saying goodbye to one pill once a day. Such drugs could be used for both treatment and prevention. Here’s a review of the research so far.

What's Hot in HIV Cure Research? Img

What's Hot in HIV Cure Research?

When it comes to an HIV cure, what do we know now and what are the main areas of focus for future research? Irini Sereti, M.D., reviewed and analyzed the current strategies in cure research, during a presentation at IDWeek 2016 in New Orleans.

Promo Image

Top Menu Items From the Boiling Cauldron of HIV Clinical Research

Leading HIV clinician-researcher Carlos Del Rio, M.D., recently gave a whirlwind tour of 18 major studies that are among the most groundbreaking new scientific findings in HIV over the past 12 months.

Promo Image

What's Hot in HIV Cure Research?

When it comes to an HIV cure, what do we know now and what are the main areas of focus for future research? Irini Sereti, M.D., reviewed and analyzed the current strategies in cure research, during a presentation at IDWeek 2016 in New Orleans.

HIV Research Preview for IDWeek 2016 Img

HIV Research Preview for IDWeek 2016

Here's a look at some of the noteworthy HIV research being presented at IDWeek 2016 in New Orleans from Oct. 25 to 30.